New Drug for Fragile X

Life can be challenging for parents of children who exhibit agitation and behavioral withdrawal.

Sometimes there is an underlying medical reason for these behaviors as is the case for children with an inherited disorder known as Fragile X.

Now, researchers at the University of Oklahoma Health Sciences Center hope to learn if an investigational drug can make a difference.

The study at the University of Oklahoma Health Sciences Center is open to patients diagnosed with Fragile X who are between five and 25 years of age.

For more information about the clinical trial, call (405)271-5700. Ext. 45167


JavaScript is disabled!
To display this content, you need a JavaScript capable browser.

 

In this Video

Nolan Dickerson
Diagnosed with Fragile X

Jessica Dickerson
Nolan's Mother

Dr. Thomas Lock
OU Department of Pediatrics

 




 

Subscribe

Keep up to date.

Subscribe to our
e-newsletter.

Copyright © 2014. University Hospitals Authority and Trust. Website by Evergreen Productions

S5 Box

Login Form

S5 Register

*
*
*
*
*

Fields marked with an asterisk (*) are required.